scispace - formally typeset
O

Olga Corti

Researcher at University of Paris

Publications -  74
Citations -  10564

Olga Corti is an academic researcher from University of Paris. The author has contributed to research in topics: Parkin & PINK1. The author has an hindex of 38, co-authored 65 publications receiving 9509 citations. Previous affiliations of Olga Corti include French Institute of Health and Medical Research & Pierre-and-Marie-Curie University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease

TL;DR: An impressive set of data in different model systems strongly suggest that mitochondrial dysfunction plays a central role in clinically similar, early-onset autosomal recessive PD forms caused by parkin and PINK1, and possibly DJ-1 gene mutations.
Journal ArticleDOI

Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse

TL;DR: It is shown that inactivation of the parkin gene in mice results in motor and cognitive deficits, inhibition of amphetamine-induced dopamine release and inhibition of glutamate neurotransmission, and the levels of dopamine are increased in the limbic brain areas of parkin mutant mice and there is a shift towards increased metabolism of dopamine by MAO.
Journal ArticleDOI

Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death

TL;DR: Results suggest that Parkin may promote the degradation of substrates localized in mitochondria and involved in the late mitochondrial phase of ceramide-mediated cell death, which may underlie the degeneration of nigral dopaminergic neurons in patients with Parkin mutations.